Literature DB >> 4637152

Hypertension and hyperparathyroidism.

F D Rosenthal, S Roy.   

Abstract

Of 40 patients with primary hyperparathyroidism 13 were hypertensive. Nine presented with hypertension and, of these, seven were discovered to have hyperparathyroidism by the routine determination of serum calcium in 900 patients referred for investigation of hypertension. The association of hypertension and hyperparathyroidism is well recognized but the cause is in doubt. The incidence of primary hyperparathyroidism in patients with hypertension is about 1 in 130, which is considerably higher than in the general population (1 in 1,000-2,000). All patients with hypertension should have a routine serum calcium estimation. Parathyroidectomy in these otherwise asymptomatic cases may prevent renal damage.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4637152      PMCID: PMC1786698          DOI: 10.1136/bmj.4.5837.396

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  7 in total

1.  ASSOCIATION OF HYPERURICAEMIA AND GOUT WITH HYPERPARATHYROIDISM.

Authors:  J T SCOTT; A S DIXON; E G BYWATERS
Journal:  Br Med J       Date:  1964-04-25

2.  Hypertension in hyperparathyroidism.

Authors:  J HELLSTROM; G BIRKE; C A EDVALL
Journal:  Br J Urol       Date:  1958-03

3.  Parathyroidectomy for symptomless hyperparathyroidism: a surgical dilemma.

Authors:  M H Gough; R Smith; M C Bishop
Journal:  Lancet       Date:  1971-06-05       Impact factor: 79.321

4.  Serum calcium survey for hyperparathyroidism: results in 50,000 clinic patients.

Authors:  C E Boonstra; C E Jackson
Journal:  Am J Clin Pathol       Date:  1971-05       Impact factor: 2.493

Review 5.  Primary hyperparathyroidism.

Authors:  L N Pyrah; A Hodgkinson; C K Anderson
Journal:  Br J Surg       Date:  1966-04       Impact factor: 6.939

6.  Calcareous renal disease and hyperparathyroidism.

Authors:  J M George; A S Rabson; A Ketcham; F C Bartter
Journal:  Q J Med       Date:  1965-07

7.  Correlations among hyperuricemia, hypercholesterolemia, coronary disease and hypertension.

Authors:  A P Hall
Journal:  Arthritis Rheum       Date:  1965-10
  7 in total
  17 in total

1.  Hyperparathyroidism in Black patients.

Authors:  E H Rosero; E B Chung; J E White; L S Leffall
Journal:  J Natl Med Assoc       Date:  1975-03       Impact factor: 1.798

Review 2.  The role of calcium supplementation in the treatment of hypertension. Current evidence.

Authors:  D E Grobbee; H J Waal-Manning
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

3.  Intracellular calcium and blood pressure: comparison between primary hyperparathyroidism and essential hypertension.

Authors:  C Fardella; J A Rodriguez-Portales
Journal:  J Endocrinol Invest       Date:  1995-12       Impact factor: 4.256

Review 4.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

5.  Time to end a conservative treatment for mild hyperparathyroidism.

Authors:  J C Stevenson; J A Lynn
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-09

6.  Effect of chronic elevation of plasma calcium concentration by PTH or vitamin D3 on blood pressure and hypotensive activity of nifedipine in rats.

Authors:  F A Jonkman; M J Thoolen; B Wilffert; A de Jonge; P B Timmermans; P A van Zwieten
Journal:  Pflugers Arch       Date:  1984-12       Impact factor: 3.657

7.  Parathyroid hypertension.

Authors:  A K Sangal; D G Beevers
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12

8.  Endocrine abnormalities in primary hyperparathyroidism.

Authors:  D V Hamilton; J S Pryor
Journal:  Postgrad Med J       Date:  1981-03       Impact factor: 2.401

9.  Effect of parathyroidectomy on cardiovascular reactivity in rats with mineralocorticoid-induced hypertension.

Authors:  A Berthelot; A Gairard
Journal:  Br J Pharmacol       Date:  1978-02       Impact factor: 8.739

10.  Changes in blood pressure and renal function after parathyroidectomy in primary hyperparathyroidism.

Authors:  D B Jones; J H Jones; H J Lloyd; P A Lucas; W E Wilkins; D A Walker
Journal:  Postgrad Med J       Date:  1983-06       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.